Sue Friedman

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline

Isabelle Bedrosian, Mark R. Somerfield, Maria Isabel Achatz et al. · Journal of Clinical Oncology · 2024 · 145 citations

Utilization and Outcomes of<i>BRCA</i>Genetic Testing and Counseling in a National Commercially Insured Population

Joanne Armstrong, Michele Toscano, Nancy Kotchko et al. · JAMA Oncology · 2015 · 125 citations

Attitudes of high-risk women toward preimplantation genetic diagnosis

Gwendolyn P. Quinn, Susan T. Vadaparampil, Crystal Wilson et al. · Fertility and Sterility · 2008 · 79 citations · Full text

Infertility, Genetic Testing, Fertility +11

Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers

Laura L. Holman, Sue Friedman, Molly S. Daniels et al. · Gynecologic Oncology · 2014 · 76 citations · Full text

Surgical Oncology, Medicine, Brca Mutation Carriers +7